Alamarbio
2 known investors
Alamar Biosciences develops the NULISA ultra-high-sensitivity, multiplexed proteomics assay and the ARGO automation platform for detecting low-abundance proteins in blood and other fluid samples. Its technology is used by researchers and clinical labs for blood-based biomarker profiling in areas such as Alzheimer's disease, neurodegeneration, and immune proteome analysis.</parameter> <parameter name="founders">[{"full_name": "Steve Williams", "title": "Chief Scientific Officer"}, {"full_name": "McAnear", "title": "Chief Financial Officer"}]